Lv4
460 积分 2023-07-21 加入
Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
7天前
已完结
Next-Generation Sequencing and Emerging Technologies
7天前
已完结
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions
18天前
已完结
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial
25天前
已完结
EP.06F.06 Concurrent DNA and RNA NGS Testing to Characterize Rare Fusions in Advanced NSCLC Patients
1个月前
已关闭
The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials
1个月前
已完结
PD-L1 Status and Survival in Patients With Lung Cancer
2个月前
已完结
Mechanisms of primary resistance to immune checkpoint inhibitors in NSCLC
2个月前
已完结
Chemotherapy and interferon‐α treatment of Erdheim–chester disease
3个月前
已完结
Erdheim–Chester disease: a rapidly evolving disease model
3个月前
已完结
皖公网安备34019202002308
